Kathryn O Czervionke, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 1064 County Road 156, Town Creek, AL 35672 Phone: 256-762-4241 |
News Archive
FibroGen, Inc. today announced initiation of a phase 2 study to compare the efficacy of FG-3019, a human monoclonal antibody against connective tissue growth factor (CTGF), with placebo in reversing liver fibrosis (scarring of the liver) due to chronic infection with hepatitis B virus (HBV).
Do people get caught in the cycle of overeating and drug addiction because their brain reward centers are over-active causing them to experience greater cravings for food or drugs? In a unique prospective study Oregon Research Institute senior scientist Eric Stice, Ph.D., and colleagues tested this theory, called the reward surfeit model.
In the first study of its kind, researchers discovered that rifaximin, an antibiotic used to treat diarrhea, is an effective treatment for abdominal bloating and flatulence, including in irritable bowel syndrome (IBS) patients.
Radiant Research, Inc. today announced that it is expanding its consumer products testing capabilities through creation of a new division of Radiant Research devoted to consumer trial conduct.
› Verified 8 days ago